C12N 15/8645
Adeno-associated virus
Official title: {Adeno-associated virus}
C12N15/8645 (Adeno-associated virus) appears on 181 US grants and 347 published applications in this corpus.
Search patents in C12N- Granted patents
- 181
- Published applications
- 347
- Assignees
- 158
- Inventors
- 575
- Latest grant
- 28 Jul 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 2003 | 0 | 1 |
| 2004 | 0 | 1 |
| 2005 | 0 | 0 |
| 2006 | 0 | 0 |
| 2007 | 1 | 2 |
| 2008 | 0 | 3 |
| 2009 | 0 | 3 |
| 2010 | 1 | 4 |
| 2011 | 0 | 2 |
| 2012 | 2 | 1 |
| 2013 | 2 | 12 |
| 2014 | 1 | 9 |
| 2015 | 8 | 7 |
| 2016 | 5 | 15 |
| 2017 | 9 | 19 |
| 2018 | 8 | 23 |
| 2019 | 16 | 49 |
| 2020 | 16 | 21 |
| 2021 | 31 | 38 |
| 2022 | 17 | 23 |
| 2023 | 23 | 25 |
| 2024 | 16 | 16 |
| 2025 | 11 | 22 |
| 2026 | 14 | 51 |
By publication year. 2026 runs to 8 Oct.
Recent patents
- Tissue selective transgene expression28 Jul 2026US 12,692,516 B2Encoded Therapeutics, Inc.
- Targeting peptides for directing adeno-associated viruses (AAVs)16 Jun 2026US 12,653,904 B2California Institute of Technology
- Recombinant adeno-associated virus delivery of exon 2-targeted U7SNRNA polynucleotide constructs16 Jun 2026US 12,655,427 B2Research Institute At Nationwide Children's Hospital
- CA2-IL15 fusion proteins for tunable regulation2 Jun 2026US 12,642,792 B2Obsidian Therapeutics, Inc.
- Virus AAV/IGF2, genetic treatment method and use thereof in protein misfolding-related diseases, such as Huntington's disease2 Jun 2026US 12,642,872 B2Universidad De Chile
- Kinetically controlled methods to prepare concentrated shelf-stable nucleic acid transfection vehicles8 Oct 2026US 2026/0308631 A1The Johns Hopkins University
- Dual aav vectors for treating stargardt disease1 Oct 2026US 2026/0295092 A1Atsena Therapeutics, Inc.
- Nannochloropsis-producing viruses and methods and compositions for making the same1 Oct 2026US 2026/0297502 A1Insmed Incorporated
- Cell1 Oct 2026US 2026/0297622 A1Antion Biosciences SA
- Novel Fragile X Constructs1 Oct 2026US 2026/0297623 A1uniQure biopharma B.V.
Most cited
By later US patents
- Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor288US 7,282,199 B2The Trustees of the University of Pennsylvania · 2007
- Adeno-associated virus (AAV) serotype 8 sequences, vectors containing the same, and uses therefor220US 7,790,449 B2The Trustees of the University of Pennsylvania · 2010
- Adeno-associated virus (AAV) serotype 8 sequences, vectors containing same, and uses therefor91US 8,318,480 B2The Trustees of the University of Pennsylvania · 2012
- CNS targeting AAV vectors and methods of use thereof91US 9,102,949 B2University of Massachusetts · 2015
- Viral vectors for the treatment of diabetes86US 11,085,055 B22021